Literature DB >> 23087412

Extensions of criteria for evaluating risk prediction models for public health applications.

Ruth M Pfeiffer1.   

Abstract

We recently proposed two novel criteria to assess the usefulness of risk prediction models for public health applications. The proportion of cases followed, PCF(p), is the proportion of individuals who will develop disease who are included in the proportion p of individuals in the population at highest risk. The proportion needed to follow-up, PNF(q), is the proportion of the general population at highest risk that one needs to follow in order that a proportion q of those destined to become cases will be followed (Pfeiffer, R.M. and Gail, M.H., 2011. Two criteria for evaluating risk prediction models. Biometrics 67, 1057-1065). Here, we extend these criteria in two ways. First, we introduce two new criteria by integrating PCF and PNF over a range of values of q or p to obtain iPCF, the integrated PCF, and iPNF, the integrated PNF. A key assumption in the previous work was that the risk model is well calibrated. This assumption also underlies novel estimates of iPCF and iPNF based on observed risks in a population alone. The second extension is to propose and study estimates of PCF, PNF, iPCF, and iPNF that are consistent even if the risk models are not well calibrated. These new estimates are obtained from case-control data when the outcome prevalence in the population is known, and from cohort data, with baseline covariates and observed health outcomes. We study the efficiency of the various estimates and propose and compare tests for comparing two risk models, both of which were evaluated in the same validation data.

Entities:  

Mesh:

Year:  2012        PMID: 23087412      PMCID: PMC3695651          DOI: 10.1093/biostatistics/kxs037

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  10 in total

1.  Polygenic susceptibility to breast cancer and implications for prevention.

Authors:  Paul D P Pharoah; Antonis Antoniou; Martin Bobrow; Ron L Zimmern; Douglas F Easton; Bruce A J Ponder
Journal:  Nat Genet       Date:  2002-03-04       Impact factor: 38.330

2.  Analyzing a portion of the ROC curve.

Authors:  D K McClish
Journal:  Med Decis Making       Date:  1989 Jul-Sep       Impact factor: 2.583

3.  Weighted Area Under the Receiver Operating Characteristic Curve and Its Application to Gene Selection.

Authors:  Jialiang Li; Jason P Fine
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2010-08       Impact factor: 1.864

4.  Two criteria for evaluating risk prediction models.

Authors:  R M Pfeiffer; M H Gail
Journal:  Biometrics       Date:  2010-12-14       Impact factor: 2.571

5.  Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.

Authors:  Andrew J Stephenson; Peter T Scardino; James A Eastham; Fernando J Bianco; Zohar A Dotan; Paul A Fearn; Michael W Kattan
Journal:  J Natl Cancer Inst       Date:  2006-05-17       Impact factor: 13.506

6.  20-year outcomes following conservative management of clinically localized prostate cancer.

Authors:  Peter C Albertsen; James A Hanley; Judith Fine
Journal:  JAMA       Date:  2005-05-04       Impact factor: 56.272

7.  A parametric ROC model-based approach for evaluating the predictiveness of continuous markers in case-control studies.

Authors:  Y Huang; M S Pepe
Journal:  Biometrics       Date:  2009-12       Impact factor: 2.571

8.  Colorectal cancer risk prediction tool for white men and women without known susceptibility.

Authors:  Andrew N Freedman; Martha L Slattery; Rachel Ballard-Barbash; Gordon Willis; Bette J Cann; David Pee; Mitchell H Gail; Ruth M Pfeiffer
Journal:  J Clin Oncol       Date:  2008-12-29       Impact factor: 44.544

9.  Validation of a colorectal cancer risk prediction model among white patients age 50 years and older.

Authors:  Yikyung Park; Andrew Nathan Freedman; Mitchell H Gail; David Pee; Albert Hollenbeck; Arthur Schatzkin; Ruth M Pfeiffer
Journal:  J Clin Oncol       Date:  2008-12-29       Impact factor: 44.544

10.  An IL28B genotype-based clinical prediction model for treatment of chronic hepatitis C.

Authors:  Thomas R O'Brien; James E Everhart; Timothy R Morgan; Anna S Lok; Raymond T Chung; Yongwu Shao; Mitchell L Shiffman; Myhanh Dotrang; John J Sninsky; Herbert L Bonkovsky; Ruth M Pfeiffer
Journal:  PLoS One       Date:  2011-07-08       Impact factor: 3.240

  10 in total
  3 in total

1.  Inference for the difference in the area under the ROC curve derived from nested binary regression models.

Authors:  Glenn Heller; Venkatraman E Seshan; Chaya S Moskowitz; Mithat Gönen
Journal:  Biostatistics       Date:  2017-04-01       Impact factor: 5.279

2.  Risk prediction to inform surveillance of chronic kidney disease in the US Healthcare Safety Net: a cohort study.

Authors:  Yuxiang Xie; Marlena Maziarz; Delphine S Tuot; Glenn M Chertow; Jonathan Himmelfarb; Yoshio N Hall
Journal:  BMC Nephrol       Date:  2016-06-08       Impact factor: 2.388

3.  Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia.

Authors:  Yeli Wang; Francis Ngoc Hoang Long Nguyen; John C Allen; Jasmine Quan Lan Lew; Ngiap Chuan Tan; Tazeen H Jafar
Journal:  BMC Nephrol       Date:  2019-12-04       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.